Systemic arterial blood pressure and the eye

Eye

Volumn 10, Issue 1, 1996, Pages 5-28

  Hayreh, Sohan Singh ^a,b  

^a University Hospitals and Clinics ^*

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; TERAZOSIN;

ADULT; AGED; ARTERIAL PRESSURE; ARTERIOLE; AUTONOMIC NERVOUS SYSTEM; AUTOREGULATION; BLOOD EYE BARRIER; BLOOD FLOW; CHOROID DISEASE; EYE; EYE FUNDUS; FEMALE; HUMAN; HYPERTENSION; HYPERTENSION RETINOPATHY; HYPOTENSION; MALE; OPTIC NERVE DISEASE; PATHOGENESIS; PERFUSION PRESSURE; RETINA ARTERY; RETINA DETACHMENT; REVIEW; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE;

EID: 0029883743     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/eye.1996.3     Document Type: Article

References (85)

1. Hayreh SS. Adventure in three worlds. Surv Ophthalmol 1991;35:317-24.
2. Page LB. Epidemiology of hypertension. In: Genest J. Kuchel O, Hamet P, Cantin M, editors. Hypertension: physiopathology and treatment, 2nd ed. New York: McGraw-Hill, 1983:683-99.
3. Kannel WB, Sorlic P. Hypertension in Framingham. In: Paul O, editor. Epidemiology and control of hypertension. New York: Stratton, 1975:553-92.
4. Hayreh SS. Anterior ischemic optic neuropathy. New York: Springer, 1975.
5. Hayreh SS. Pathogenesis of optic nerve damage and visual field defects. In: Heilmann K, Richardson KT, editors. Glaucoma: conceptions of a disease. Stuttgart: Thieme, 1978:104-37, 405-11.
6. Hayreh SS. Central retinal vein occlusion. In: Mausolf FA, editor. The eye and systemic disease. St Louis: CV Mosby, 1980:223-75.
7. Hayreh SS. Die Bedeutung vasculaerer Faktoren in der Pathogenese des Glaukomschadens. In: Pillunat LE. Stodtmeister R, editors. Das Glaukom. Heidelberg: Springer, 1993:34-58.
8. Hayreh SS, Joos KM, Podhajsky PA, Long CR. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1994: 118:766-80.
9. Hayreh SS. Progress in the understanding of the vascular etiology of glaucoma. Curr Opin Ophthalmol 1994;5:26-35.
10. Hayreh SS, Zimmerman BM, Podhajsky P, Alward WLM. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 1994;117:603-24.
11. Kishi S, Tso MOM, Hayreh SS. Fundus lesions in malignant hypertension. I. A pathologic study of experimental hypertensive choroidopathy. Arch Ophthalmol 1985;103:1189-97.
12. Kishi S, Tso MOM, Hayreh SS. Fundus lesions in malignant hypertension. II. A pathologic study of experimental hypertensive optic neuropathy. Arch Ophthalmol 1985;103:1198-206.
13. Hayreh SS, Servais GE, Virdi PS. Fundus lesions in malignant hypertension. III. Arterial blood pressure, biochemical, and fundus changes. Ophthalmology 1986;93:45-59.
14. Hayreh SS. Servais GE, Virdi PS. Fundus lesions in malignant hypertension. IV. Focal intraretinal periarteriolar transudates. Ophthalmology 1986;93:60-73.
15. Hayreh SS, Servais GE, Virdi PS. Fundus lesions in malignant hypertension. V. Hypertensive optic neuropathy. Ophthalmology 1986;93:74-87.
16. Hayreh SS, Servais GE, Virdi PS. Fundus lesions in malignant hypertension. VI. Hypertensive choroidopathy. Ophthalmology 1986;93:1383-400.
17. Hayreh SS, Servais GE. Retinal hemorrhages in malignant arterial hypertension. Int Ophthalmol 1988; 12:137-45.
18. Hayreh SS. Hypertensive retinopathy: introduction. Ophthalmologica 1989;198:173-7.
19. Hayreh SS, Servais GE, Virdi PS. Retinal arteriolar changes in malignant arterial hypertension. Ophthalmologica 1989;198:178-96.
20. Hayreh SS, Servais GE, Virdi PS. Cotton-wool spots (inner retinal ischemic spots) in malignant arterial hypertension. Ophthalmologica 1989;198:197-215.
21. Hayreh SS, Servais GE, Virdi PS. Retinal lipid deposits in malignant arterial hypertension. Ophthalmologica 1989;198:216-29.
22. Hayreh SS, Servais GE, Virdi PS. Macular lesions in malignant arterial hypertension. Ophthalmologica 1989;198:230-46.
23. Hayreh SS. Classification of hypertensive fundus changes and their order of appearance. Ophthalmologica 1989;198:247-60.
24. Hayreh SS. Malignant arterial hypertension and the eye. Ophthalmol Clin North Am 1992;5:445-73.
25. Hayreh SS, Bill A, Sperber GO. Effects of high intraocular pressure on the glucose metabolism in the retina and optic nerve in old atherosclerotic monkeys. Graefes Arch Clin Exp Ophthalmol 1994;232:745-52.
26. Hayreh SS, Podhajsky P. Ocular neovascularization with retinal vascular occlusion. II. Occurrence in central and branch retinal artery occlusion. Arch Ophthalmol 1982;100:1585-96.
27. Hayreh SS. Factors determining the glaucomatous optic nerve damage. In: Krieglstein GK, editor. Glaucoma Update III. Heidelberg: Springer, 1987: 40-6.
28. Hayreh SS. The optic nerve head circulation in health and disease. Exp Eye Res 1995;61:259-72.
29. Haefliger IO, Meyer P, Flammer J, Luescher TF. The vascular endothelium as a regulator of the ocular circulation: a new concept in ophthalmology? Surv Ophthalmol 1994;39:123-32.
30. Luescher TF. The endothelium and cardiovascular disease: a complex relationship. N Engl J Med 1994;330:1081-3.
31. Hayreh SS. Fluids in the anterior part of the optic nerve in health and disease. Surv Ophthalmol 1978;23: 1-25.
32. Genest J, Kuchel O, Hamet P, Cantin M. Physiopathology of experimental and human hypertension. In: Hypertension: physiopathology and treatment, 2nd ed. New York: McGraw-Hill, 1983:3-675.
33. Liebreich R. Ophthalmoskopischer Befund bei Morbus Brightii. Albrecht von Graefes Arch Ophthalmol 1859; 5(2):265-8.
34. Ashton N. The eye in malignant hypertension. Trans Am Acad Ophthalmol Otolaryngol 1972;76:17-40.
35. Garner A, Ashton N, Tripathi R, Kohner EM, Bulpitt CJ, Dollery CT. Pathogenesis of hypertensive retinopathy: an experimental study in the monkey. Br J Ophthalmol 1975;59:3-44.
36. de Venecia G, Wallow I, Houser D, Wahlstrom M. The eye in accelerated hypertension. I. Elschnig's spots in nonhuman primates. Arch Ophthalmol 1980;98:913-8.
37. Tso MOM, Jampol LM. Pathophysiology of hypertensive retinopathy. Ophthalmology 1982;89:1132-45.
38. Hodge JV, Dollery CT. Retinal soft exudates: a clinical study by colour and fluorescence photography. Q J Med 1964;33:117-31.
39. Dollery CT. Hypertensive retinopathy. In: Genest J, Kuchel O, Hamet P, Cantin M, editors. Hypertension: physiopathology and treatment, 2nd ed. New York: McGraw-Hill, 1983:723-32.
40. Henkind P. New observations on the radial peripapillary capillaries. Invest Ophthalmol 1967;6:103-8.
41. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci 1939;197:332-43.
42. Kincaid-Smith P. Malignant hypertension: mechanisms and management. Pharmacol Ther 1980;9:245-69.
43. McGregor E, Isles CG, Jay JL, Lever AF, Murray GD. Retinal changes in malignant hypertension. BMJ 1986;292:233-4.
44. Wagener HP, Clay GE, Gipner JF. Classification of retinal lesions in the presence of vascular hypertension. Trans Am Ophthalmol Soc 1947;45:57-73.
45. Scheie HG. Evaluation of ophthalmoscopic changes of hypertension and arteriolar sclerosis. Arch Ophthalmol 1953;49:117-38.
46. Leishman R. The eye in general vascular disease: hypertension and arteriosclerosis. Br J Ophthalmol 1957;41:641-701.
47. Cogan DG. Ophthalmic manifestations of systemic vascular disease. Philadelphia: WB Saunders, 1974: 74-8.
48. Tso MOM, Jampol LM. Pathophysiology of hypertensive retinopathy. Ophthalmology 1982;89:1132-45.
49. Leighton DA, Phillips CI. Systemic blood pressure in open-angle glaucoma, low-tension glaucoma, and the normal eye. Br J Ophthalmol 1972;56:447-53.
50. Chumbley LC, Brubaker RF. Low-tension glaucoma. Am J Ophthalmol 1976;81:761-7.
51. Levene RZ. Low-tension glaucoma: a critical review and new material. Surv Ophthalmol 1980;24:621-64.
52. Goldberg I, Hollow FC, Kass MA, Becker B. Systemic factors in patients with low-tension glaucoma. Br J Ophthalmol 1981;65:56-62.
53. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Hypertension, perfusion pressure, and primary open angle glaucoma. Arch Ophthalmol 1995;113:216-21.
54. Cruickshank JM, Pennert K, Sorman AE, Thorp JM, Zacharias FM, Zacharias FJ. Low mortality from all causes, including myocardial infarction, in well-controlled hypertensives treated with a beta-blocker plus other anti-hypertensives. J Hypertens 1987;5:489-98.
55. Kaplan NM, Alderman MH, Flamenbaum W, McCarron DA, Perry HM, Saunders E, Schroenberger JA. Guidelines for the treatment of hypertension. Am J Hypertens 1989;2:75-7.
56. Berglund G. Goals of hypertensive therapy: is there a point beyond which pressure reduction is dangerous? Am J Hypertens 1989;2:586-93.
57. Fletcher AE, Bulpitt CJ. How far should blood pressure be lowered? N Engl J Med 1992;326:251-4.
58. Farnett L, Mulrow CD, Lin WD, Lucey CR. Tuley MR. The J-curve phenomenon and treatment of hypertension: Is there a point beyond which pressure reduction is dangerous? JAMA 1991;265:489-95.
59. Cooper SP, Hardy RJ, Labarthe DR, Hawkins CM, Smith EO, Blaufox MD, et al. The relation between degree of blood pressure reduction and mortality among hypertensives in the Hypertension Detection and Follow-up Program. Am J Epidemiol 1988;127: 387-402.
60. Alderman MH, Ooi WL, Madhavan S, Cohen H. Treatment induced blood pressure reduction and the risk of myocardial infarction. JAMA 1989;262:920-4.
61. Coope J. Hypertension: the cause of the J-curve. J Hum Hypertens 1990;4:1-4.
62. Hayreh SS. Anterior ischaemic optic neuropathy. I. Terminology and pathogenesis. Br J Ophthalmol 1974; 58:955-63.
63. Hayreh SS. Anterior ischemic optic neuropathy. Arch Neurol 1981;38:675-8.
64. Hayreh SS. Anterior ischaemic optic neuropathy: differentiation of arteritic from non-arteritic type and its management. Eye 1990;4:25-41.
65. Richardson DW, Honour AJ, Fenton GW, Stott FH, Pickering GW. Variation in arterial pressure throughout the day and night. Clin Sci 1964;26:445-60.
66. Weber MA, Drayer JIM. Ambulatory blood pressure monitoring. Darmstadt: Steinkopff, 1984.
67. Floras JS. Antihypertensive treatment, myocardial infarction, and nocturnal myocardial ischaemia. Lancet 1988;2:994-6.
68. Schwartz B.Fluorescein angiography: its contribution to evaluation of the optic disc and the retinal circulation in glaucoma. In: Lambrou GN, Greve EL, editors. Ocular blood flow in glaucoma: means, methods and measurements. Amstelveen: Kugler & Ghedini, 1989:243-54.
69. Hayreh SS. Anterior ischaemic optic neuropathy. II. Fundus on ophthalmoscopy and fluorescein angiography. Br J Ophthalmol 1974;58:964-80.
70. Hayreh SS. Inter-individual variation in blood supply of the optic nerve head: its importance in various ischemic disorders of the optic nerve head, and glaucoma, low-tension glaucoma and allied disorders. Doc Ophthalmol 1985;59:217-46.
71. Guthauser U, Flammer J, Mahler F. The relationship between digital and ocular vasospasm. Graefes Arch Clin Exp Ophthalmol 1988;226:224-6.
72. Drance SM, Douglas GR, Wijsman K, Schulzer M, Britton RJ. Response of blood flow to warm and cold in normal and low-tension glaucoma patients. Am J Ophthalmol 1988;105:35-9.
73. Hayreh SS. In vivo choroidal circulation and its watershed zones. Eye 1990;4:273-89.
74. McLean JM. Management of the primary glaucomas. Am J Ophthalmol 1957;44:323-34.
75. Reese AB, McGavic JS. Relation of field contraction to blood pressure in chronic primary glaucoma. Arch Ophthalmol 1942;27:845-50.
76. Francois J, Neetens A. The deterioration of the visual field in glaucoma and the blood pressure. Doc Ophthalmol 1970;28:70-132.
77. Heilmann K. Augendruck, Blutdruck und Glaukomschaden. Stuttgart: Ferdinand Enke, 1972.
78. Sachsenweger R. Der Einfluss des Bluthochdruckes auf die Prognose des Glaukoms. Klin Monatsbl Augenheilkd 1963;142:625-33.
79. Drance SM, Wheeler C, Pattullo M. Uniocular openangle glaucoma. Am J Ophthalmol 1968;65:891-902.
80. Graham SL, Drance SM, Wijsman K, Douglas GR, Mikelberg FS. Ambulatory blood pressure monitoring in glaucoma: the nocturnal dip. Ophthalmology 1995; 102:61-9.
81. Tso MOM, Hayreh SS. Optic disc edema in raised intracranial pressure. III. A pathologic study of experimental papilledema. Arch Ophthalmol 1977; 95:1448-57.
82. Hayreh SS. Optic disc edema in raised intracranial pressure. V. Pathogenesis. Arch Ophthalmol 1977; 95:1553-65.
83. Hayreh SS. Optic disc edema in raised intracranial pressure. VI. Associated visual disturbances and their pathogenesis. Arch Ophthalmol 1977;95:1566-79.
84. Hayreh SS, Klugman MR, Beri M, Kimura AE, Podhajsky P. Differentiation of ischemic from nonischemic central retinal vein occlusion during the early acute phase. Graefes Arch Klin Exp Ophthalmol 1990; 228:201-17.
85. Hayreh SS. Ophthalmic features of giant cell arteritis. Clin Rheumatol 1991;5:431-59.